Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT03596255 Completed - Dental Anxiety Clinical Trials

Clinical Estimation of Dental Anxiety

Start date: September 1, 2017
Phase:
Study type: Observational

Introduction: Dental anxiety (DA) is treatable and preventable when dental personnel correctly estimate the patient's level of DA. Objective: To evaluate dental personnel's ability to estimate DA.

NCT ID: NCT03593473 Completed - Anxiety Disorders Clinical Trials

Inhaled Oxytocin and HPA Axis Reactivity

Start date: February 7, 2019
Phase: Phase 2
Study type: Interventional

Mothers who were enrolled in the Mood, Mother and Infant study will be eligible to participate in the 6-year follow-up maternal visit. At the time of this visit, mothers will be randomized to a single 24 IU dose of nasal oxytocin or placebo. Following administration of the study drug, women will participate in the Trier Social Stress Test (TSST), and blood samples will be collected to quantify HPA axis reactivity.

NCT ID: NCT03591224 Completed - Depression Clinical Trials

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

Start date: April 17, 2018
Phase: N/A
Study type: Interventional

A randomized controlled trial comparing pharmacogenomic guided versus standard pharmacist care to optimize antidepressant drug therapy. This study evaluates the effectiveness of pharmacists utilizing pharmacogenomic testing in the community pharmacy setting to help patients find the most appropriate drug therapy option(s) and minimize the risk of side effects in collaboration with prescribing physicians.

NCT ID: NCT03586921 Completed - Depression Clinical Trials

Primary Care Group Therapy for Depression/Anxiety for Women in Petropolis

Start date: May 19, 2006
Phase: Phase 3
Study type: Interventional

This is a randomized controlled trial comparing two groups: 1) Enhanced usual care and 2) Enhanced usual care plus group psychological intervention. In both groups a "stepped care" approach was used to the management of anxiety and depression among women seen in primary care.

NCT ID: NCT03581097 Completed - Anxiety Disorders Clinical Trials

Educational Video and Peri-operative Anxiety

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

Preoperative anxiety is a common problem with an impact on surgical outcome, anaesthetic drug dosage and patient's satisfaction. An important component of preoperative anxiety is due to concerns related to anaesthesia. Appropriate patients information has been shown to reduce preoperative anxiety level and this can be effectively achieved through a video. The aim of this study is to assess the impact of an informative video about the anaesthesia technique on patient's preoperative anxiety levels before minor ambulatory procedures. The study design is a prospective, randomized, controlled clinical trial, where we use of short patient educational video to reduce preoperative anxiety level, explaining all sequence of major events between the arrival in the operating room and the performance of anaesthesia.

NCT ID: NCT03578393 Completed - Anxiety Clinical Trials

Efficacy of a Preoperative Virtual Reality Intervention as a Paediatric Anxiety Improvement Strategy

Start date: February 2, 2019
Phase: N/A
Study type: Interventional

This study evaluate the effectiveness of the Virtual Reality Educational Program (RVEP) in the Paediatric Surgical Prehabilitation Unit to reduce the perioperative anxiety in children who undergo to elective surgery. Half of the patients will received the virtual reality program, and the other half will received de common treatment.

NCT ID: NCT03577106 Completed - Clinical trials for Anxiety Disorders Generalized

A Pilot fMRI Study of TMS in Late-Life Severe Worry

TINA
Start date: December 6, 2018
Phase: N/A
Study type: Interventional

Investigators will test a novel intervention through experimental therapeutic approach using fMRI-directed Intermittent Theta Burst Stimulation (iTBS), a high frequency TMS paradigm, for the treatment of severe, uncontrollable worry. While worry is a universal human experience, severe and excessive worry has been recently linked to increased risk of stroke and other cardiovascular diseases, increased risk of conversion to Alzheimer's disease as well as to higher risk of all-cause mortality in midlife and late-life. Severe, uncontrollable worry has been repeatedly associated with reduced quality of life and impaired functioning. Current treatment choices (antidepressant/anxiolytic medications and psychotherapeutic interventions) have been proven moderately efficacious in reducing anxiety/depression burden, but ineffective in reducing worry severity, a phenomenon that may contribute to the high relapse rates associated with mood and anxiety disorders. Our research indicated that worry severity is associated with hyperactivation in specific regions such as orbital frontal cortex, superior parietal gyrus, amygdala and parahippocampal gyrus. This pilot study will explore the efficacy of targeting one of these regions with iTBS. Based on investigators' previous results, the most accessible target is the right superior parietal gyrus (rSPG) - a region that remained significantly associated with severe worry after controlling for effects of comorbid depression or overall anxiety. As this region showed an increased in cerebrovascular flow in association with worry severity, investigators will use iTBS (5x/week for 2 weeks) to modulate cortical plasticity in this region and consequently, to reduce worry severity. TMS during wakefulness has been shown to alter subsequent sleep [4], Further, changes in sleep in response to TMS has been associated with how participants respond to the TMS as a treatment [5]. Thus, the study will measure sleep throughout the protocol to determine whether sleep changes as a function of TMS and whether sleep changes are associated with treatment response.

NCT ID: NCT03576482 Completed - Depression Clinical Trials

Emotional Impact of the Way Conducting Cancer Patients to the Surgical Center

Start date: January 7, 2019
Phase:
Study type: Observational

Cancer is an extremely aggressive disease, anxiety and depression are consequences some patients may develop from diagnosis continuing during treatment. A measures control of the cancer is surgery for removal tumor. The surgical procedure is often a difficult experience for patients and their relatives, and patients in the preoperative period are often psychological symptoms of anxiety and depression. A previous study with the objective analyzing patient's emotional repercussion according the type of transport to the surgical center reached the following result: patients who go to the surgical center feel more relaxed in the preoperative period. The primary objective is to analyze emotional repercussion of patient diagnosed with cancer classified in Eastern Cooperative Oncology Group (ECOG) Performance Status 0 and 1 according type transport to the surgical center.

NCT ID: NCT03566212 Completed - Behavior Clinical Trials

Efficacy of Camouflaged Syringe vs Conventional Syringe

ECC
Start date: August 13, 2017
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of Camouflage syringe vs Conventional syringe in reducing Dental Anxiety and increasing behaviour rating.Half of the participants received local anesthesia using camouflaged syringe, while others received using conventional syringe.

NCT ID: NCT03562650 Completed - Social Anxiety Clinical Trials

Text Message Treatment for Social Anxiety

Start date: January 27, 2018
Phase: N/A
Study type: Interventional

This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.